Free Gout Diagnosis Calculator

Assessing gout risk through clinical criteria such as podagra diagnosis criteria can be complex, but a dedicated Gout Assessment Tool like this Gout Risk Score helps clinicians systematically estimate the probability of an acute flare. Built on established Gout Clinical Criteria, this Gout Screening Tool incorporates key clinical findings and uric acid assessment to support diagnostic decision‑making.

Gout is one of the most common joint diseases, affecting roughly 1 in 25 adults in the United States during their lifetime. An acute flare is marked by rapid‑onset inflammation, most frequently in the first metatarsophalangeal (big toe) joint, which becomes red, swollen, and tender. Typical patients are overweight men who have previously been diagnosed with at least one cardiovascular condition. Although elevated serum uric acid is a hallmark of gout, it is not always present; nevertheless, measuring blood urate remains an important part of the workup.

Clinical Criteria Used in the Calculator

The tool evaluates the presence of five key features:

Criterion	Description
Painful joint inflammation	Acute red, swollen, tender first MTP joint (the most common site)
Serum uric acid	Elevated level (above the laboratory reference range)
Patient’s sex	Male
Prior medical history	Previously diagnosed cardiovascular disease or arthritis
Symptom onset	Abrupt onset within 24 hours

Elevated serum uric acid is linked to higher body mass index and alcohol consumption. Clinicians may complement this assessment with a BMI calculator and an alcohol use screening questionnaire for a more complete evaluation.

Interpreting the Total Risk Score

After answering the clinical questions, the tool generates a total score that stratifies patients into three risk groups:

• Score 4 or less – Gout prevalence is about 2.2 %. The diagnosis is unlikely, and additional workup may not be necessary.
• Score between 4 and 7.5 – Prevalence increases to roughly 31.2 %. Gout is possible, and further investigation—such as synovial fluid analysis—is recommended.
• Score above 7.5 – Prevalence reaches approximately 80.4 %. A diagnosis of gout is strongly supported, and treatment can be initiated without extensive confirmatory testing.

These thresholds provide a practical framework for deciding when to treat empirically and when to pursue additional diagnostic evaluation.

Managing an Acute Gout Attack

Acute and chronic gout require different therapeutic strategies. For an acute flare, the primary goal is rapid suppression of inflammation. The following medications are typically used:

• Colchicine (specific dosing protocol below)
• Non‑steroidal anti‑inflammatory drugs (NSAIDs), such as indomethacin
• Corticosteroids, reserved for patients who cannot tolerate colchicine or NSAIDs

Colchicine Dosing Regimen

The recommended dosage for acute gout follows a three‑step schedule:

1. First dose: 1.2 mg.
2. Second dose: 0.6 mg, taken one hour after the first dose.
3. Maintenance: 0.6 to 1.2 mg per day for the following days, as needed and as tolerated.

⚠️ This tool is designed to assist clinical assessment and does not replace a professional medical evaluation. If you suspect you have gout, please consult a qualified healthcare provider for diagnosis and treatment.